FDA proposes to ease rules on off-label drug use

02/17/2008 | NYTimes.com

The FDA on Friday recommended new guidelines that would let drug and medical-device makers supply doctors with copies of journal articles on off-label uses of their products. Advocates say the proposal would give physicians access to credible scientific data that could potentially save lives, while critics argue that allowing such a practice could compromise patient safety and result in unreliable research on the benefits of drugs and devices.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health